QUOTE AND NEWS
Benzinga  Nov 18  Comment 
Analysts at Credit Suisse upgraded Thoratec (NASDAQ: THOR) from Neutral to Outperform. The price target for Thoratec has been raised from $27.00 to $35.00. Thoratec shares have dropped 30.46% over the past 52 weeks, while the S&P 500 index has...
Benzinga  Nov 18  Comment 
Market Intelligence Center  Nov 10  Comment 
After Friday’s trading in Thoratec (THOR) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 3.82% or 8.83% (for comparison purposes only), while providing 10.58% downside...
TheStreet.com  Oct 28  Comment 
NEW YORK (TheStreet) -- Shares ofaThoratec Corp. aare sinking, down 2.97% to $25.51, in early market trading after the medical devices company had its rating lowered to "equal weight" from "overweight" by analysts at investment firm...
Market Intelligence Center  Oct 21  Comment 
After Monday’s trading in Thoratec (THOR) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 5.65% or 23.43% (for comparison purposes only), while providing 6.28% downside...
StreetInsider.com  Oct 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Thoratec+%28THOR%29+Adds+New+North+America+President/9889891.html for the full story.
Market Intelligence Center  Oct 2  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Thoratec (THOR) that includes 10.94% downside protection. Sell one contract of the Jan. '15...
SeekingAlpha  Sep 29  Comment 
By Andy Batts: Thoratec (NASDAQ:THOR) announced that D. Keith Grossman has been appointed president and chief executive officer, effective immediately. Mr. Grossman succeeds Gary F. Burbach, who has stepped down from his CEO and board positions....





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki